Rigel Pharmaceuticals RIGL
NASDAQ RIGL
$47.15 +0.18 (+0.38%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rigel Pharmaceuticals (RIGL) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Rigel Pharmaceuticals (RIGL) recorded Return on Capital Employed [ROCE] of 20.86% in Q2 2026, down 79.01 percentage points from 99.87% a year earlier and down 8.83 percentage points from the prior quarter.

Analysis

Rigel Pharmaceuticals (RIGL) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025, Rigel Pharmaceuticals reported Return on Capital Employed [ROCE] of 52.38%, up 21.08 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has increased for three straight years, with a five-year change of +85.25 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at 31.30% in FY2024 (+59.56 pp), -28.27% in FY2023 (+36.63 pp), -64.90% in FY2022 (-48.31 pp) and -16.60% in FY2021 (+16.28 pp).
  • The Q2 2026 figure is the lowest quarterly Return on Capital Employed [ROCE] since Q3 2024.
  • On a year-over-year basis, Return on Capital Employed [ROCE] rose in six of the last eight quarters, with an average year-over-year change of +36.60 percentage points.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 112.98 percentage points in Q2 2025, against a drop of 98.70 percentage points in Q3 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at 29.69% (Q1 2026), 45.00% (Q4 2025) and 91.34% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Rigel Pharmaceuticals 880.76 Mn 346.64 Mn 70.18 Mn 20.86%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.86%
Mar 31, 2026 29.69%
Dec 31, 2025 45.00%
Sep 30, 2025 91.34%
Jun 30, 2025 99.87%
Mar 31, 2025 42.51%
Dec 31, 2024 27.37%
Sep 30, 2024 11.94%
Jun 30, 2024 -13.10%
Mar 31, 2024 -30.27%
Dec 31, 2023 -32.52%
Sep 30, 2023 -30.00%
Jun 30, 2023 -44.96%
Mar 31, 2023 -50.36%
Dec 31, 2022 -93.00%
Sep 30, 2022 -106.05%
Jun 30, 2022 -96.23%
Mar 31, 2022 -81.34%
Dec 31, 2021 -11.02%
Sep 30, 2021 -7.35%
API Access

Rigel Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=RIGL&period=max&api_key=YOUR_API_KEY